{"id":214522,"title":"Archived 25: Summary of NACI rapid response of December 3, 2021: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T18:51:36.537000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines/summary.html?wbdisable=false","snippet":"Archived 25: Summary of NACI rapid response of December 3, 2021: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 - Canada.ca Skip to main…","rawSnapshotUrl":"/api/snapshots/raw/214522","browseUrl":"https://replay.healtharchive.ca/job-1/20250418185136/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines/summary.html?wbdisable=false#ha_snapshot=214522","mimeType":"text/html","statusCode":200}